Salek, S.; Ionova, T.; Oliva, E.N.; Andreas, M.; Skoetz, N.; Kreuzberger, N.; Laane, E.
The Reporting, Use, and Validity of Patient-Reported Outcomes in Multiple Myeloma in Clinical Trials: A Systematic Literature Review. Cancers 2022, 14, 6007.
https://doi.org/10.3390/cancers14236007
AMA Style
Salek S, Ionova T, Oliva EN, Andreas M, Skoetz N, Kreuzberger N, Laane E.
The Reporting, Use, and Validity of Patient-Reported Outcomes in Multiple Myeloma in Clinical Trials: A Systematic Literature Review. Cancers. 2022; 14(23):6007.
https://doi.org/10.3390/cancers14236007
Chicago/Turabian Style
Salek, Sam, Tatiana Ionova, Esther Natalie Oliva, Marike Andreas, Nicole Skoetz, Nina Kreuzberger, and Edward Laane.
2022. "The Reporting, Use, and Validity of Patient-Reported Outcomes in Multiple Myeloma in Clinical Trials: A Systematic Literature Review" Cancers 14, no. 23: 6007.
https://doi.org/10.3390/cancers14236007
APA Style
Salek, S., Ionova, T., Oliva, E. N., Andreas, M., Skoetz, N., Kreuzberger, N., & Laane, E.
(2022). The Reporting, Use, and Validity of Patient-Reported Outcomes in Multiple Myeloma in Clinical Trials: A Systematic Literature Review. Cancers, 14(23), 6007.
https://doi.org/10.3390/cancers14236007
